Advertisement

Topics

Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines

19:00 EST 8 Nov 2018 | BioSpace

AcelRx is seeking $40 million to support the launch of Dsuvia and Sarepta eyes $500 million to support clinical research.

Original Article: Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines

NEXT ARTICLE

More From BioPortfolio on "Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...